FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307113721> ?p ?o ?g. }

• W4307113721 endingPage "28" @default.
• W4307113721 startingPage "20" @default.
• W4307113721 abstract "Neutralizing antibodies (NAbs) can be indicators of collective immunity, vaccine efficacy, and the longevity of the humoral response. This study aimed to compare reactogenicity and NAbs generated by three different COVID-19 vaccine platforms in individuals with and without prior COVID-19. 336 individuals vaccinated (112 with CoronaVac [inactivated virus], 112 with BNT162b2 [messenger RNA], and 112 with Ad5-nCoV [non-replicating viral vector]) were included. NAbs were quantified with the cPass SARS-CoV-2 kit. Individuals immunized with the Ad5-nCoV showed higher reactogenicity than those immunized with the other vaccines (p < 0.001). The BTN162b2 vaccine-induced NAbs with higher inhibition capacity than the other platforms in the first dose. In individuals without prior COVID-19, the Ad5-nCoV vaccine generated lower NAbs against SARS-CoV-2 than those induced by two doses of the BTN162b2 (Ad5-nCoV 72.10 [55.6-93.4] vs. BTN162b2 98.41 [98.16-98.56], p < 0.0001). One individual did not generate NAbs (0.89%) after a complete immunization with CoronaVac; in BTN162b2, all generated these antibodies, and in the Ad5-nCoV group, four individuals (3.57%) did not generate NAbs. Comorbidities, gender, age, and reactogenicity did not significantly influence the generation of NAbs (p > 0.05); however, a history of COVID-19 before vaccination was associated with antibodies with greater neutralizing capacity after the first dose (p < 0.01). In conclusion, the mRNA vaccine (BTN162b2) had a remarkable better ability to produce NAbs and lower reactogenicity than the other platforms, whereas the Ad5-nCov vaccine induced the lowest NAbs response in individuals without a history of COVID-19; therefore, we suggest that a booster could benefit these individuals." @default.
• W4307113721 created "2022-10-27" @default.
• W4307113721 creator A5010249854 @default.
• W4307113721 creator A5011489099 @default.
• W4307113721 creator A5054085119 @default.
• W4307113721 creator A5054539295 @default.
• W4307113721 creator A5056929301 @default.
• W4307113721 creator A5063545722 @default.
• W4307113721 creator A5064606791 @default.
• W4307113721 creator A5071410755 @default.
• W4307113721 creator A5088168825 @default.
• W4307113721 date "2022-12-01" @default.
• W4307113721 modified "2023-10-17" @default.
• W4307113721 title "Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies" @default.
• W4307113721 cites W2008391100 @default.
• W4307113721 cites W2049624058 @default.
• W4307113721 cites W2112011162 @default.
• W4307113721 cites W2606304149 @default.
• W4307113721 cites W2736112898 @default.
• W4307113721 cites W2782708334 @default.
• W4307113721 cites W2891486793 @default.
• W4307113721 cites W2921553057 @default.
• W4307113721 cites W2923453408 @default.
• W4307113721 cites W3044482768 @default.
• W4307113721 cites W3092136311 @default.
• W4307113721 cites W3097453900 @default.
• W4307113721 cites W3100745755 @default.
• W4307113721 cites W3102328262 @default.
• W4307113721 cites W3115317977 @default.
• W4307113721 cites W3128869316 @default.
• W4307113721 cites W3129321699 @default.
• W4307113721 cites W3135416503 @default.
• W4307113721 cites W3146894320 @default.
• W4307113721 cites W3155262144 @default.
• W4307113721 cites W3156150675 @default.
• W4307113721 cites W3161032756 @default.
• W4307113721 cites W3163785571 @default.
• W4307113721 cites W3169082905 @default.
• W4307113721 cites W3177804396 @default.
• W4307113721 cites W3179119084 @default.
• W4307113721 cites W3180567859 @default.
• W4307113721 cites W3182870240 @default.
• W4307113721 cites W3185577988 @default.
• W4307113721 cites W3188612134 @default.
• W4307113721 cites W3189612030 @default.
• W4307113721 cites W3192803358 @default.
• W4307113721 cites W3196659412 @default.
• W4307113721 cites W3199893854 @default.
• W4307113721 cites W3200343502 @default.
• W4307113721 cites W3203242093 @default.
• W4307113721 cites W3208958190 @default.
• W4307113721 cites W3209216075 @default.
• W4307113721 cites W3211414543 @default.
• W4307113721 cites W4206914007 @default.
• W4307113721 cites W4210704633 @default.
• W4307113721 cites W4212835565 @default.
• W4307113721 cites W4212880839 @default.
• W4307113721 cites W4221042703 @default.
• W4307113721 cites W4285042528 @default.
• W4307113721 cites W4285797779 @default.
• W4307113721 doi "https://doi.org/10.1016/j.imlet.2022.10.002" @default.
• W4307113721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36279685" @default.
• W4307113721 hasPublicationYear "2022" @default.
• W4307113721 type Work @default.
• W4307113721 citedByCount "3" @default.
• W4307113721 countsByYear W43071137212022 @default.
• W4307113721 countsByYear W43071137212023 @default.
• W4307113721 crossrefType "journal-article" @default.
• W4307113721 hasAuthorship W4307113721A5010249854 @default.
• W4307113721 hasAuthorship W4307113721A5011489099 @default.
• W4307113721 hasAuthorship W4307113721A5054085119 @default.
• W4307113721 hasAuthorship W4307113721A5054539295 @default.
• W4307113721 hasAuthorship W4307113721A5056929301 @default.
• W4307113721 hasAuthorship W4307113721A5063545722 @default.
• W4307113721 hasAuthorship W4307113721A5064606791 @default.
• W4307113721 hasAuthorship W4307113721A5071410755 @default.
• W4307113721 hasAuthorship W4307113721A5088168825 @default.
• W4307113721 hasBestOaLocation W43071137212 @default.
• W4307113721 hasConcept C126322002 @default.
• W4307113721 hasConcept C159047783 @default.
• W4307113721 hasConcept C159654299 @default.
• W4307113721 hasConcept C203014093 @default.
• W4307113721 hasConcept C22070199 @default.
• W4307113721 hasConcept C2777704310 @default.
• W4307113721 hasConcept C2779134260 @default.
• W4307113721 hasConcept C2779261636 @default.
• W4307113721 hasConcept C2780868878 @default.
• W4307113721 hasConcept C3007834351 @default.
• W4307113721 hasConcept C3008058167 @default.
• W4307113721 hasConcept C524204448 @default.
• W4307113721 hasConcept C71924100 @default.
• W4307113721 hasConceptScore W4307113721C126322002 @default.
• W4307113721 hasConceptScore W4307113721C159047783 @default.
• W4307113721 hasConceptScore W4307113721C159654299 @default.
• W4307113721 hasConceptScore W4307113721C203014093 @default.
• W4307113721 hasConceptScore W4307113721C22070199 @default.
• W4307113721 hasConceptScore W4307113721C2777704310 @default.
• W4307113721 hasConceptScore W4307113721C2779134260 @default.

• next